Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community

BACKGROUND: Strongyloides seroprevalence is hyper-endemic in many Australian Aboriginal and Torres Strait Islander communities, ranging from 35–60%. We report the impact on Strongyloides seroprevalence after two oral ivermectin mass drug administrations (MDAs) delivered 12 months apart in a remote A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kearns, Therese M., Currie, Bart J., Cheng, Allen C., McCarthy, James, Carapetis, Jonathan R., Holt, Deborah C., Page, Wendy, Shield, Jennifer, Gundjirryirr, Roslyn, Mulholland, Eddie, Ward, Linda, Andrews, Ross M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444847/
https://www.ncbi.nlm.nih.gov/pubmed/28505198
http://dx.doi.org/10.1371/journal.pntd.0005607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444847/
https://www.ncbi.nlm.nih.gov/pubmed/28505198
http://dx.doi.org/10.1371/journal.pntd.0005607

Ejemplares similares